Royalty Pharma PLC (Class A) - RPRX - stock price prediction, stock price target, analyst ratings from 9 analysts

Royalty Pharma PLC (Class A) has a share price target of US$ 47, revenue growth forecast of 14.3%, and profit growth estimate of 45.9% for FY25, based on top 9 analyst calls.